Table 2 Different F3II tumor response types after electrochemical therapy application by experimental group and gender
Groups | Gender | F3II tumor responses after EChT application | Overall effectiveness (%) (PR + CR) | |||
|---|---|---|---|---|---|---|
PD (%) | SD (%) | PR (%) | CR (%) | |||
TG1 | F (N = 10) | 1 (10.0) | 4 (40.0) | 5 (50.0) | 0 (0.0) | 5 (50.0) |
M (N = 10) | 1 (10.0) | 3 (30.0) | 6 (60.0) | 0 (0.0) | 6 (60.0) | |
TG2 | F (N = 6) | 1 (16.7) | 1 (16.7) | 4 (66.6) | 0 (0.0) | 4 (66.6) |
M (N = 5) | 0 (0.0) | 1 (20.0) | 4 (80.0) | 0 (0.0) | 4 (80.0) | |
TG3 | F (N = 5) | 1 (20.0) | 1 (10.0) | 3 (30.0) | 0 (0.0) | 3 (30.0) |
M (N = 8) | 2 (25.0) | 3 (25.0) | 4 (50.0) | 0 (0.0) | 4 (50.0) | |
TG4 | F (N = 7) | 2 (28.6) | 3 (42.8) | 2 (28.6) | 0 (0.0) | 2 (28.6) |
M (N = 8) | 2 (25.0) | 3 (37.5) | 4 (50.0) | 0 (0.0) | 4 (50.0) | |
TG5 | F (N = 5) | 1 (20.0) | 1 (20.0) | 2 (40.0) | 0 (0.0) | 2 (40.0) |
M (N = 7) | 1 (14.4) | 3 (42.8) | 3 (42.8) | 0 (0.0) | 3 (42.8) | |
TG6 | F (N = 6) | 1 (16.7) | 2 (33.3) | 3 (50.0) | 0 (0.0) | 3 (50.0) |
M (N = 5) | 1 (20.0) | 2 (40.0) | 2 (40.0) | 0 (0.0) | 2 (40.0) | |